Epinephrine Administered in Anaphylaxis: The Evolution of 0.3 mg Dosage.
Peyton CoadyKenneth L DretchenMichael MesaPublished in: Therapeutic advances in allergy and rhinology (2023)
This retrospective review illustrates the drug development process prior to the rigors required for today's clinical trials and provides clinical evidence supporting the dose in EpiPen and other similar life-saving epinephrine products.
Keyphrases